Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancer

Published:2016-03-01 Issue:3 Volume:17 Page:252-257
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Gusella M,Giacopuzzi S,Bertolaso L,Zanoni A,Pezzolo E,Modena Y,Menon D,Paganin P,Weindelmayer J,Crepaldi G,De Manzoni G,Pasini F

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.nature.com/articles/tpj20169.pdf

Reference19 articles.

1. Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J . Australasian Gastro-Intestinal Trials Group. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007; 8: 226–342.

2. Sjoquist KM, Burmeister BH, Smithers BM, Zalcberg JR, Simes RJ, Barbour A et al. Australasian Gastro-Intestinal Trials Group. Survival after neoadjuvant chemotherapy or chemoradiotherapy for respectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 2011; 12: 681–692.

3. Pasini F, de Manzoni G, Zanoni A, Grandinetti A, Capirci C, Pavarana M et al. Neoadjuvant therapy with weekly docetaxel and cisplatin, 5-fluorouracil continuous infusion, and concurrent radiotherapy in patients with locally advanced esophageal cancer produced a high percentage of long-lasting pathological complete response: a phase 2 study. Cancer 2013; 119: 939–945.

4. Pezzolo E, Modena Y, Corso B, Giusti P, Gusella M . Germ line polymorphisms as predictive markers for pre-surgical radiochemotherapy in locally advanced rectal cancer: a 5-year literature update and critical review. Eur J Clin Pharmacol 2015; 71: 529–539.

5. Gusella M, Pasini F, De Manzoni G . Role of molecular biology in the prediction of response to neoadjuvant treatment. In: De Manzoni G (ed). Treatment of Esophageal and Hypopharyngeal Squamous Cell Carcinoma chapter 7. Springer, 2012 pp 69–76.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies;Frontiers in Oncology;2022-04-21

2. Different response rates to chemotherapy between Japanese and German esophageal squamous cell carcinoma: patients may be influenced by ERCC1 or ABCB1;Future Oncology;2020-09

3. Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy;BMC Cancer;2019-10-26

4. Relevance ofMTHFRpolymorphisms with response to fluoropyrimidine-based chemotherapy in oesophagogastric cancer: a meta-analysis;BMJ Open;2018-05

5. ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer;International Journal of Molecular Sciences;2018-03-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3